Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Shuo Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1087-9974; OpenAlex author ID A5100366859. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2022.13227↗
  2. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2018.8219↗
  3. Prometastatic mechanisms of CAF-mediated EMT regulation in pancreatic cancer cells. First author DOI 10.3892/ijo.2016.3779↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Shan · 3 shared papers, 2017–2022 · strength 0.28
  2. Ya’an Kang · 3 shared papers, 2017–2022 · strength 0.28
  3. Wenbin Yang · 2 shared papers, 2018–2022 · strength 0.21
  4. Gang Cao · 2 shared papers, 2018–2022 · strength 0.21
  5. Xi Chen · 2 shared papers, 2017–2018 · strength 0.14
  6. Wei Li · 1 shared paper, 2018 · strength 0.07
  7. Li Wang · 1 shared paper, 2018 · strength 0.07
  8. Hong Long Ji · 1 shared paper, 2017 · strength 0.06
  9. Wěi Li · 1 shared paper, 2017 · strength 0.06
  10. Tao Wu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.